Page last updated: 2024-08-23

paclitaxel and Astrocytoma, Grade IV

paclitaxel has been researched along with Astrocytoma, Grade IV in 162 studies

Research

Studies (162)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (11.11)	18.2507
2000's	37 (22.84)	29.6817
2010's	75 (46.30)	24.3611
2020's	32 (19.75)	2.80

Authors

Authors	Studies
Bakalara, N; Clarion, L; Filippini, D; Hirlemann, MH; Jacquard, C; Lecouvey, M; Loiseau, S; Pirat, JL; Sainte-Catherine, O; Virieux, D; Volle, JN	1
Abbassi, RH; Day, BW; Font, JS; Hoque, M; Johns, TG; Kassiou, M; Munoz, L; Phoa, AF; Reekie, TA; Ryan, RM; Stringer, BW; Zhou, Q	1
Chen, HC; Dai, Z; Liu, H; Liu, HY; Liu, YP; Luo, XD; Wang, B; Yan, H; Yang, D; Zhao, LX; Zhao, XD; Zhao, YL; Zhu, PF; Zhu, YY	1
Kang, JH; Ko, YT; Kwon, YJ; Lee, DS; Turabee, MH	1
Ali, MY; Ebeid, K; Griguer, C; Naguib, Y; Oliva, C; Quarterman, JC; Salem, AK; Wiwatchaitawee, K	1
Chen, H; Wen, J	1
Ahmed, AU; Amidei, C; Arrieta, VA; Castro, B; Chang, CL; Chen, L; Cordero, A; Dmello, C; Gould, A; Győrffy, B; Horbinski, C; Hsu, P; Kang, SJ; Kanojia, D; Lesniak, MS; Sonabend, A; Sonabend, AM; Stupp, R; Winter, J; Zhang, DY; Zhang, J	1
Banerjee, R; Chaudhari, P; Chekuri, G; Dutt, S; Gera, P; Goda, J; Mohanty, B; Sandbhor, P; Yadav, S	1
Burek, M; Domröse, D; Ernestus, RI; Förster, CY; Giladi, M; Giniunaite, A; Hagemann, C; Hörmann, J; Kessler, AF; Löhr, M; Salvador, E; Schaeffer, C; Tempel-Brami, C; Volodin, A; Voloshin, T; Zeidan, A	1
Abu-Gharbieh, E; Abuhelwa, AY; Ahmed, M; Alqudah, MAY; Alsoud, LO; Alzoubi, KH; Bustanji, Y; El-Awady, R; El-Huneidi, W; Ramadan, WS; Semreen, AM; Semreen, MH; Shara, M; Soares, NC	1
Ashourpour, M; Kazerouni, F; Mostafavi Hosseini, F; Salami, S; Shahsavari, Z; Taheri, S; Tavakoli Yaraki, M	1
Amerhanova, S; Babaev, V; Buzyurova, D; Gaynanova, G; Kuznetsov, D; Lukashenko, S; Lyubina, A; Pavlov, R; Petrov, K; Romanova, E; Voloshina, A; Zakharova, L; Zueva, I	1
Erthal, LCS; Gobbo, OL; Ruiz-Hernandez, E; Shi, Y; Sweeney, KJ	1
Brem, H; Chakroun, RW; Chen, D; Chen, Z; Cui, H; Gorelick, N; Guan, Y; Hanes, J; Huang, Q; Monroe, MK; Serra, R; Su, H; Suk, JS; Sun, M; Tyler, B; Wang, F; Wang, H; Wang, Z; Zheng, M	1
Decuzzi, P; Di Mascolo, D; Guerriero, I; Palange, AL; Pesce, C; Spanò, R	1
Bachoo, R; Cai, Q; Fan, H; Gao, X; Ge, X; Giannotta, M; Hoyt, K; Li, J; Li, X; Maher, E; Margolis, R; Qin, Z; Vemireddy, V; Xiong, H	1
Dadey, DY; Fitzpatrick, J; Hallahan, DE; Kapoor, V; Rau, MJ; Saikia, M; Shah, HK; Singh, AK; Thotala, D; Townsend, R	1
Alinezhad, A; Behrooz, AB; Davazdahemami, AA; Hamzah, ASA; Homaie, FM; Jamalpour, S; Maddah, SM; Sabah, JT; Vazifehmand, R	1
Guan, J; Qian, J; Zhan, C	1
Schwendeman, SP	1
Caban-Toktas, S; Capan, Y; Dalkara, T; Esendagli, G; Karlı Oguz, K; Khan, M; Lule, S; Mut, M; Sahin, A; Soylemezoglu, F; Vural, I	1
Ainslie, KM; Bachelder, EM; Graham-Gurysh, EG; Hingtgen, SD; Lee, T; Moore, KM; Schorzman, AN; Zamboni, WC	1
Cai, K; Li, K; Lin, C; Lu, L; Luo, Z; Shen, X; Tao, B	1
Banerjee, R; Chaudhuri, A; Jaggarapu, MMCS; Madhusudana, K; Moku, G; Ramkrishna, S; Saha, S; Shankar, G; Srinivas, R; Yakati, V	1
Ge, Y; Liu, Y; Ren, L; Shan, W; Wang, X; Yang, J; Ye, S; Zhang, Q; Zhang, X; Zhou, X	1
Adabi, M; Bergonzi, MC; Esnaashari, SS; Khosravani, M; Madani, F; Webster, TJ; Younes, HM	1
Black, KL; Butte, P; Chung, LWK; Perez, JM; Reichel, D; Sagong, B; Teh, J; Wagner, S; Wang, H; Yu, JS; Zhang, Y	1
Bernstein, AM; Deming, TJ; Garrett, MC; Hung, D; Kornblum, HI; O'Shea, TM; Sofroniew, MV; Soto, H; Staarman, B; Wollenberg, AL	1
Bazzazzadeh, A; Dizaji, BF; Irani, M; Kianinejad, N; Nouri, A	1
Chen, W; Di, Q; Ma, W; Ma, X; Sun, P; Wang, Q; Xiao, Y	1
Guo, Y; Li, D; Li, Z; Su, W; Wang, Y	1
Ghosh, S; Gupta, V; Joseph, MM; Maiti, KK; Maniganda, S; Mohapatra, S; Nair, JB	1
Almaimani, RA; Almasmoum, HA; Alrobaian, M; Baothman, AA; Beg, S; Choudhry, H; Ghaith, MM; Ibrahim, IAA; Panda, SK; Shen, L; Singh, T; Wang, L; Wang, X	1
Adabi, M; Ghanbari, H; Hadjighassem, MR; Hosseini Najafabadi, MR; Khosravani, M; Maleki, H; Sadroddiny, E; Webster, TJ	1
Ali, J; Baboota, S; Mittal, S	1
Behrooz, AB; Masarudin, MJ; Masomian, M; Sekawi, Z; Syahir, A; Tajudin, AA; Vazifehmand, R	1
Chang, CW; Chen, HH; Chiang, CS; Chiang, WH; Chiu, HC; Huang, WC; Lin, YW; Lu, IL; Tsai, YC	1
Alessandri, G; Benetti, A; Berenzi, A; Cadei, M; Ceserani, V; Ciusani, E; Ferri, A; Ferroli, P; Finocchiaro, G; Pallini, R; Parati, E; Pessina, A; Restelli, F; Schiariti, MP	1
Alessandri, G; Aralla, M; Bonomi, A; Brini, AT; Ceserani, V; Coccè, V; Ghezzi, E; Guercio, A; Parati, E; Pascucci, L; Pessina, A; Pettinari, L; Zeira, O	1
Chen, S; Chen, X; Diao, X; Hu, Y; Pi, Z; Shen, Y; Yan, F; Yeh, CK; Zeng, X; Zheng, H	1
Fu, J; Jiang, Y; Lv, L; Wang, X; Xin, H; Yao, Q; Zhang, Q	1
Gao, L; Han, L; Lu, W; Nan, L; Peng, T; Sun, L; Wang, J; Wang, Y; Yan, Z; Yu, J; Yu, L; Zhang, L; Zhao, S; Zhou, J	1
Auslander, N; Ben-Shushan, D; Calderón, M; Eldar-Boock, A; Ferber, S; Grossman, R; Haag, R; Henkin, J; Krivitsky, A; Licha, K; Ofek, P; Ram, Z; Ruppin, E; Satchi-Fainaro, R; Scomparin, A; Sousa-Herves, A; Tiram, G; Vossen, LI; Yeini, E	1
Chang, KR; Ihsan, A; Javed, I; Madni, A; Rehman, M; Shi, D; Tahir, N; Webster, TJ	1
Hu, Y; Jiang, T; Jiang, X; Jin, K; Liu, X; Luo, Z; Pang, Z; Shen, S; Tuo, Y; Wang, H; Zhang, B	1
Fisusi, FA; Schätzlein, AG; Uchegbu, IF	1
Jiang, P; Li, Y; Liu, X; Tang, C; Wu, M; Yan, F; Zhang, N; Zheng, H	1
Bastiancich, C; Bianco, J; Danhier, F; Gallez, B; Ganipineni, LP; Jankovski, A; Joudiou, N; Préat, V; Rieux, AD; Tsakiris, N; Zhao, M	1
Hong, SP; Kang, BS; Kang, SH	1
Bastiancich, C; Bianco, J; Danhier, F; Danhier, P; Gallez, B; Ganipineni, LP; Joudiou, N; Préat, V; Ucakar, B; Zhao, M	1
Borrós, S; Brugada Vilà, P; Cascante, A; Di Mauro, PP; Gómez-Vallejo, V; Llop, J	1
Bastiancich, C; Bastiat, G; Bozzato, E; Danhier, F; Luyten, U; Préat, V	1
Altshuler, D; Castro, MG; Doherty, R; Edwards, M; Kadiyala, P; Kamran, N; Kuai, R; Li, D; Lowenstein, PR; Moon, JJ; Nuñez, FM; Schwendeman, A; Yu, M	1
Braidy, N; Günaydın, C; Nazıroğlu, M; Öztürk, Y; Yalçın, F	1
Chakroun, RW; Cui, H; Lin, R; Pompa, D; Su, H; Wang, F; Wang, Y	1
Asser, T; Bergers, G; Bjerkvig, R; Friedmann-Morvinski, D; Hunt, H; Kotamraju, VR; Lingasamy, P; Mastandrea, I; Paiste, P; Rätsep, T; Rousso-Noori, L; Ruoslahti, E; Säälik, P; Simón-Gracia, L; Teesalu, T; Tobi, A; Toome, K	1
Bozzato, E; Danhier, F; Gallez, B; Ghiassinejad, S; Joudiou, N; Préat, V; Zhao, M	1
Ahmadi-Zeidabadi, M; Esmaeeli, M; Forootanfar, H; Pardakhty, A; Pournamdari, M; Salarpour, S	1
Cai, X; Fu, W; Li, S; Lin, S; Lin, Y; Shao, X; Shi, S; Tang, Z; Tian, T; Zhang, T; Zhang, Y; Zhou, Y	1
Barazas, M; De Witt Hamer, PC; Geerts, D; Gray, NS; Hagemann, C; Hiddingh, L; Kerami, M; Kessler, AF; Kwiatkowski, N; Lagerweij, T; Lewandrowski, G; Niers, JM; Nilsson, RJ; Noske, DP; Sol, N; Tannous, BA; Van der Stoop, PM; Van Tellingen, O; Vandertop, WP; Wang, J; Wedekind, L; Würdinger, T; Zhou, W	1
Kim, SS; Kim, SY; Lim, SH; Seong, S	1
Brons, S; Combs, SE; Debus, J; Haberer, T; Schlaich, F; Weber, KJ	1
Borrós, S; Di Mauro, PP	1
Gao, Y; Hedstrom, L; Kuang, Y; Long, MJ; Shi, J; Xu, B; Xu, C; Zhou, J	1
Gao, H; Jiang, X; Pang, Z; Qian, Y; Wei, Y; Wu, J; Yang, Z; Yu, Y; Zhang, B; Zhao, J	1
Annovazzi, L; Battaglia, L; Biasibetti, E; Caldera, V; Capucchio, MT; Chirio, D; Corona, S; Filice, G; Gallarate, M; Lanotte, M; Mellai, M; Muntoni, E; Panciani, P; Peira, E; Riganti, C; Schiffer, D; Valazza, A	1
Alessandri, G; Bonomi, A; Cavicchini, L; Ciusani, E; Coccè, V; Dossena, M; Frigerio, S; Lisini, D; Mantegazza, R; Marfia, G; Navone, SE; Parati, E; Pessina, A; Rampini, P; Rimoldi, M; Rizzetto, M; Sisto, F	1
Agrawal, U; Chashoo, G; Kumar, A; Saxena, AK; Sharma, PR; Vyas, SP	1
Annovazzi, L; Battaglia, L; Caldera, V; Chirio, D; Melcarne, A; Mellai, M; Riganti, C; Schiffer, D	1
Annovazzi, L; Biunno, I; Cassoni, P; Cattaneo, M; De Blasio, P; Melcarne, A; Mellai, M; Schiffer, D; Storaci, AM	1
Chen, Q; Feng, L; Li, Y; Liu, Z; Wang, C; Wang, X	1
Chen, H; Chen, J; Feng, X; Gao, X; Jiang, D; Jiang, M; Kang, T; Song, Q; Yao, J	1
Chen, J; Feng, X; Gao, X; Jiang, D; Jiang, X; Jing, Y; Kang, T; Liang, J; Song, Q; Yao, J	1
Bade, D; Bicker, U; Bludszuweit-Philipp, C; Geltmeier, A; Maier, P; Meditz, K; Rinner, B; Witt, R	1
Benoit, JP; Couez, D; Franconi, F; Lemaire, L; Lollo, G; Ullio-Gamboa, G; Vincent, M	1
Alessandri, G; Bonomi, A; Coccè, V; D'Alessandris, QG; De Pascalis, I; Falchetti, ML; Giannetti, S; Morgante, L; Pacioni, S; Pallini, R; Pascucci, L; Pessina, A	1
Jiang, Y; Liu, X; Lv, L; Lv, W; Wang, B; Wang, Z; Xin, H; Xu, Q; Zhao, Y	1
Boxerman, J; Coyle, T; DiPetrillo, T; Donahue, JE; Elinzano, H; Evans, D; Glantz, M; Hebda, N; Kesari, S; Kim, L; Mantripragada, K; Mitchell, KM; Mrugala, M; Pan, E; Piccioni, DE; Rosati, KL; Safran, H; Timothy, K; Yunus, S	1
Duan, Y; Gao, P; Shen, M; Sun, Y; Xu, Y	1
Duan, Y; Li, Y; Shen, M; Sun, Y; Teng, Y; Wang, Y; Xu, Y	1
Chen, J; Feng, J; Feng, X; Gao, X; Jiang, D; Jiang, T; Jiang, X; Jing, Y; Kang, T; Song, Q; Yao, J; Zhu, Q	1
Castro, MG; Doherty, R; Lowenstein, PR; Wilson, TJ; Zamler, DB	1
Jiang, T; Jiang, X; Jin, K; Liu, X; Lu, H; Luo, Z; Pang, Q; Pang, Z; Yan, Z; Yu, L	1
Mu, Q; Stephen, ZR; Wang, H; Wang, K; Yu, Y; Zhang, M; Zhou, S	1
Alessandri, G; Bonomi, A; Buccarelli, M; Coccè, V; D'Alessandris, QG; Falchetti, ML; Giannetti, S; Morgante, L; Pacioni, S; Pallini, R; Pascucci, L; Pessina, A; Ricci-Vitiani, L	1
Chang, KC; Eun, SY; Ham, SA; Han, CW; Jang, HS; Kim, HJ; Kim, JH; Lee, JH; Seo, HG; Woo, IS	1
Banik, NL; Ray, SK; Zhang, R	1
Banik, NL; Butler, JT; Janardhanan, R; Ray, SK	1
Lee, HS; Lee, LY; Lu, F; Ong, BY; Ranganath, SH; Sahinidis, NV; Wang, CH	1
Banik, NL; George, J; Ray, SK	2
Benoit, JP; Garcion, E; Jarnet, D; Menei, P; Paillard, A; Vinchon-Petit, S	1
Dicker, DT; Dorsey, JF; Dowling, ML; El-Deiry, WS; Kao, GD; Mintz, A; Plastaras, JP; Tian, X	1
Gu, B; Li, J; Liu, Y; Lu, W; Xie, C; Zhan, C	1
Han, L; Jia, ZF; Kang, CS; Mei, M; Pu, PY; Ren, Y; Wang, GX; Xu, P; Yuan, XB; Zhou, X	1
Chang, KC; Eun, SY; Hong, SC; Kang, ES; Kim, HJ; Kim, JH; Lee, JH; Seo, HG; Woo, IS	1
Arifin, DY; Chow, PK; Fu, Y; Kee, I; Lee, HS; Ranganath, SH; Wang, CH; Zheng, L	1
Chen, L; Chen, Y; Fang, X; Gu, J; Jiang, X; Luo, J; Ren, X; Sha, X; Wei, Z; Xin, H	1
Andelković, T; Banković, J; Pešić, M; Podolski-Renić, A; Ruždijić, S; Tanić, N	1
Banik, NL; Karmakar, S; Ray, SK; Roy Choudhury, S	1
Chen, L; Chen, Y; Fang, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Sha, X; Wang, X; Xin, H	1
Anelli, V; Bassi, R; Brioschi, L; Campanella, R; Caroli, M; De Zen, F; Gaini, SM; Giussani, P; Riboni, L; Riccitelli, E; Viani, P	1
Ding, D; Guo, H; Hu, H; Jiang, L; Lu, L; Ma, W; Meng, W; Xiao, K; Yu, H; Zheng, W	1
Brons, S; Combs, SE; Debus, J; Haberer, T; Habermehl, D; Rieken, S; Weber, KJ; Winter, M; Zipp, L	1
Battastini, AM; Braganhol, E; Moreira, JC; Zanotto-Filho, A	1
Feng, L; Lu, W; Qian, J; Wei, X; Zhan, C; Zhu, J	1
Chang, HY; Chang, MW; Chuang, CY; Juan, HF; Lo, JM	1
Behe, M; Braun, F; Grosu, AL; Milanović, D; Niedermann, G; Weber, W	1
Chen, L; Fang, X; Jiang, X; Sha, X; Xin, H; Zhang, W	1
Banik, NL; Hossain, M; Ray, SK	1
Banerjee, R; Joshi, N; Shanmugam, T; Thakur, A	1
Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L	1
Baumann, BC; Chapman, C; Discher, DE; Dorsey, JF; Harada, T; Kao, GD; Mahmud, A; Swift, J; Xu, X	1
Balzeau, J; Benoit, JP; Berges, R; Eyer, J; Pinier, M; Saulnier, P	1
Eichler, HG; Guensberg, P; Jansen, B; Lucas, T; Monia, B; Pehamberger, H; Wacheck, V	1
Bauer, B; Bernhardt, G; Buschauer, A; Fankhänel, M; Färber, L; Fellner, S; Fricker, G; Graeff, C; Gschaidmeier, H; Miller, DS; Schaffrik, M; Spruss, T	1
Dicker, AP; Grant, DS; Williams, TL; Zahaczewsky, M	1
Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ	1
Bombardelli, E; Cassinelli, G; D'Incalci, M; Frapolli, R; Laccabue, D; Lanzi, C; Morazzoni, P; Pratesi, G; Riva, A; Supino, R; Zucchetti, M; Zunino, F	1
Faibel, M; Hadani, M; Jonas, T; Lidar, Z; Mardor, Y; Nass, D; Pfeffer, R; Ram, Z	1
Atherton, JA; Baker, DA; Barth, W; Cohen, BD; Cooper, B; Dalvie, D; Hungerford, W; Kath, JC; Lin, J; Lyssikatos, JP; Moraski, G; Pollack, V; Ralston, S; Roberts, WG; Savage, D; Soderstrom, C; Soderstrom, E; Szewc, R; Tkalcevic, G; Ung, E; Wang, HF; Whalen, PM	1
Cromwell, LD; Fadul, CE; Kingman, LS; McDonnell, CE; Meyer, LP; Pipas, JM; Rhodes, CH; Rigas, JR	1
Gildehaus, FJ; Goldbrunner, R; Holtmannspötter, M; Kreth, FW; Pöpperl, G; Tanner, P; Tatsch, K; Tonn, JC	1
Kiwit, JC; Kratzel, C; Patt, S; Reszka, R; von Eckardstein, KL	1
Kiwit, JC; Reszka, R; von Eckardstein, KL	1
Groves, MD; Jeon, JW; Kang, CM; Kim, JH; Kim, JT; Kim, MH; Kim, YJ; Nam, DH; Park, K; Park, SY; Son, MJ; Song, HS	1
Bernhardt, G; Buschauer, A; Gartner, M; Giannis, A; Gross, D; Müller, C; Sarli, V	1
Baraldi, PG; Benini, A; Borea, PA; Gessi, S; Leung, E; Maclennan, S; Merighi, S; Mirandola, P; Varani, K	1
Baas, PW; Bertrand, L; de Chadarévian, JP; Dráber, P; Dráberová, E; Katsetos, CD; Legido, A; Nissanov, J; Reddy, G; Smejkalová, B	1
Banik, NL; Das, A; Ray, SK	2
Banik, NL; Karmakar, S; Patel, SJ; Ray, SK	1
Budinger, TF; Forte, TM; Gibbs, AR; Hunt, CA; Nikanjam, M	1
Banik, NL; Karmakar, S; Ray, SK	1
Aldape, K; Aoki, H; Bogler, O; Conrad, C; Hess, K; Hollingsworth, EF; Iwado, E; Kobayashi, R; Kondo, S; Kondo, Y; Mills, G; Sawaya, R; Shingu, T; Shinojima, N; Tamada, Y; Yamamoto, A; Yokoyama, T; Zhang, L	1
Akerley, W; Choy, H; Egorin, MJ; Glantz, MJ; Kearns, CM	1
Close, LG; Fathallah-Skaykh, H; Gazdar, AF; Griener, J; Kamen, B; Lucci, JA; Rosenthal, DI; Schold, SC; Truelson, J; Vuitch, FM	1
Chicoine, MR; Madsen, CL; Silbergeld, DL	1
Ainsworth, S; Helson, C; Helson, L; Malik, S; Mangiardi, J	1
Choy, H; Cole, BF; Egorin, MJ; Glantz, MJ; Kearns, CM; Mills, P; Rhodes, CH; Saris, S; Stopa, E; Zuhowski, EG	1
Jones, KD	1
Carbone, DP; Fathallah-Shaykh, H; Gazdar, AF; Griener, J; Hamilton, L; Landay, M; McWhorter, J; Mendelsohn, D; Okani, O; Orr, KY; Rosenthal, DI; Tourville, J; Truelson, JM; Vuitch, FM	1
Burt, HM; Davis, NL; Demetrick, JS; Hunter, WL; Liggins, RT; Machan, L	1
Arnold, H; Bjerkvig, R; Dahl, O; Gundersen, G; Heese, O; Terzis, AJ; Thorsen, F; Visted, T	1
Erlanger, B; Fetell, MR; Fisher, JD; Grossman, SA; Piantadosi, S; Rowinsky, E; Stockel, J	1
Arbit, E; Lederman, G; Lombardi, E; Odaimi, M; Wronski, M; Wrzolek, M	1
Arbit, E; Lederman, G; Lombardi, E; Odaimi, M; Wertheim, S	1
Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Koukourakis, MI; Schiza, S	1
Cordes, N; Plasswilm, L; Sauer, R	1
Boucher, Y; Brekken, C; Griffon-Etienne, G; Jain, RK; Suit, HD	1
Chamberlain, MC; Kormanik, P	1
Agarwal, S; Awasthy, BS; Julka, PK; Mahapatra, AK; Rath, GK; Singh, R; Varna, T	1
Arbit, E; Lederman, G; Lombardi, E; Odaimi, M; Wertheim, S; Wronski, M; Wrzolek, M	1
Capizzello, A; Foroglou, G; Fountzilas, G; Kalogera-Fountzila, A; Karavelis, A; Karkavelas, G; Selviaridis, P; Tourkantonis, A; Zamboglou, N	1
Beenen, LF; Heimans, JJ; Hoekstra, OS; Klein, M; Luykx, SA; Postma, TJ; Taphoorn, MJ; van Groeningen, CJ; Vermorken, JB; Zonnenberg, BA	1
Finlay, J; Glass, J; Gruber, ML; Hochster, H; Muggia, FM; Nirenberg, A; Rosenthal, MA	1
Burt, HM; D'Amours, S; Demetrick, JS; Liggins, RT; Machan, LS	1
Ikeda, J	1
Curran, W; Langer, CJ; Movsas, B; Murray, K; Paulus, R; Rhodes, H; Ruffer, J	1
Frankel, LS; Liu, L; Munoz, LK; Rosenthal, DI; Strauss, LC; Vapiwala, N; Weitman, S; Winick, NJ	1
Horowitz, J	1
Bernhardt, G; Buschauer, A; Göpferich, A; Spruss, T; Vogelhuber, W	1

Reviews

2 review(s) available for paclitaxel and Astrocytoma, Grade IV

Article	Year
Overcoming the Challenges in the Treatment of Glioblastoma via Nanocarrier- based Drug Delivery Approach. Current pharmaceutical design, 2021, Volume: 27, Issue:45 Topics: Adult; Brain; Brain Neoplasms; Drug Delivery Systems; Glioblastoma; Humans; Paclitaxel	2021
Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications. Current opinion in molecular therapeutics, 1999, Volume: 1, Issue:4 Topics: Adenoviridae; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Genes, p53; Genetic Therapy; Genetic Vectors; Glioblastoma; Head and Neck Neoplasms; Humans; Injections; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasms; Ovarian Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Recombinant Fusion Proteins; Salvage Therapy; Signal Transduction; Treatment Outcome; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	1999

Article

Year

Overcoming the Challenges in the Treatment of Glioblastoma via Nanocarrier- based Drug Delivery Approach.

Current pharmaceutical design, 2021, Volume: 27, Issue:45

Topics: Adult; Brain; Brain Neoplasms; Drug Delivery Systems; Glioblastoma; Humans; Paclitaxel

2021

Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.

Current opinion in molecular therapeutics, 1999, Volume: 1, Issue:4

Topics: Adenoviridae; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Genes, p53; Genetic Therapy; Genetic Vectors; Glioblastoma; Head and Neck Neoplasms; Humans; Injections; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasms; Ovarian Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Recombinant Fusion Proteins; Salvage Therapy; Signal Transduction; Treatment Outcome; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

1999

Trials

18 trial(s) available for paclitaxel and Astrocytoma, Grade IV

Article	Year
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244. American journal of clinical oncology, 2018, Volume: 41, Issue:2 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Polyglutamic Acid; Radiotherapy, Adjuvant; Single-Blind Method; Survival Analysis; Treatment Outcome; Tumor Suppressor Proteins; United States	2018
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. Journal of neurosurgery, 2004, Volume: 100, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Convection; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Frontal Lobe; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Parietal Lobe; Prospective Studies; Temporal Lobe	2004
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. Journal of neuro-oncology, 2005, Volume: 71, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Filgrastim; Glioblastoma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Recombinant Proteins; Thrombocytopenia; Topotecan; Treatment Outcome	2005
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:9 Topics: Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine	2005
Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions. Seminars in oncology, 1995, Volume: 22, Issue:5 Suppl 12 Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Regression Analysis; Survival Rate	1995
Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Anemia; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glioblastoma; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphopenia; Paclitaxel; Radiation-Sensitizing Agents; Remission Induction; Uterine Cervical Neoplasms	1995
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Glioblastoma; Humans; Middle Aged; Paclitaxel	1996
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies. Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 2 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Glioblastoma; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Analysis	1997
Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:9 Topics: Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chemotherapy, Adjuvant; Drug Interactions; Female; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm, Residual; Paclitaxel; Radiotherapy, Adjuvant; Survival Analysis; Time Factors; Treatment Outcome	1997
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. International journal of radiation oncology, biology, physics, 1999, Jan-01, Volume: 43, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Glioblastoma; Humans; Lung Neoplasms; Lymphocytes; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pelvic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Taxoids; Treatment Outcome	1999
Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas. Journal of neuro-oncology, 1999, Volume: 43, Issue:1 Topics: Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy	1999
A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme. Australasian radiology, 2000, Volume: 44, Issue:1 Topics: Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm, Residual; Paclitaxel; Prognosis; Radiation-Sensitizing Agents; Survival Rate	2000
Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. American journal of clinical oncology, 2000, Volume: 23, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiosurgery; Survival Analysis; Treatment Outcome	2000
Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study. Journal of neuro-oncology, 1999, Volume: 45, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy; Survival Analysis; Time Factors	1999
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:4 Topics: Adult; Affect; Aged; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Quality of Life; Survival Analysis; Treatment Outcome	2000
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme. Journal of neuro-oncology, 2000, Volume: 47, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Therapy, Combination; Estramustine; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome	2000
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Supratentorial Neoplasms	2001
A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors. Medical and pediatric oncology, 2001, Volume: 37, Issue:4 Topics: Adolescent; Brain; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Survival Analysis; Treatment Outcome	2001

Other Studies

142 other study(ies) available for paclitaxel and Astrocytoma, Grade IV

Article	Year
Oxaphosphinanes: new therapeutic perspectives for glioblastoma. Journal of medicinal chemistry, 2012, Mar-08, Volume: 55, Issue:5 Topics: Animals; Antineoplastic Agents; Astrocytes; Brain Neoplasms; Cell Count; Cell Line, Tumor; Cell Survival; Cyclic P-Oxides; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Organophosphonates; Phosphorous Acids; Rats; Stereoisomerism; Structure-Activity Relationship	2012
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5 Topics: Brain Neoplasms; Glioblastoma; Humans; Phosphorylation; Protein Kinases; Structure-Activity Relationship; Tyrosine	2017
Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A. European journal of medicinal chemistry, 2021, Jan-15, Volume: 210 Topics: Antineoplastic Agents; Apoptosis; Biological Products; Brain Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Goosecoid Protein; Humans; Molecular Structure; Saponins; Structure-Activity Relationship; Tumor Cells, Cultured	2021
Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 143 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Gelatin; Glioblastoma; Humans; Hydrogels; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Paclitaxel; Porosity; Stimuli Responsive Polymers; Sulfamethazine; Temperature; Time Factors; Viscosity; Xenograft Model Antitumor Assays	2021
Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model. Bioconjugate chemistry, 2022, 11-16, Volume: 33, Issue:11 Topics: Animals; Brain; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Glioblastoma; Humans; Lactic Acid; Mice; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Distribution	2022
Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway. European journal of pharmacology, 2022, Apr-15, Volume: 921 Topics: Animals; Autophagy; Cell Line, Tumor; Ferroptosis; Glioblastoma; Humans; Magnetic Iron Oxide Nanoparticles; Mice; Nanoparticles; Paclitaxel	2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 07-15, Volume: 28, Issue:14 Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Pharmacological; Brain Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoribonucleases; Female; Glioblastoma; Humans; Membrane Glycoproteins; Mice; Paclitaxel; Prospective Studies; Protein Serine-Threonine Kinases; Receptors, Cytoplasmic and Nuclear; Receptors, Peptide; Xenograft Model Antitumor Assays	2022
Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug delivery and translational research, 2023, Volume: 13, Issue:2 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Glioma; Mice; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Paclitaxel; Transferrin	2023
Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo. Biomolecules, 2022, 09-22, Volume: 12, Issue:10 Topics: Animals; Blood-Brain Barrier; Claudin-5; Endothelial Cells; Glioblastoma; Mice; Paclitaxel; Rats; rho-Associated Kinases	2022
Metabolomics Analysis Revealed Significant Metabolic Changes in Brain Cancer Cells Treated with Paclitaxel and/or Etoposide. International journal of molecular sciences, 2022, Nov-11, Volume: 23, Issue:22 Topics: Brain Neoplasms; Etoposide; Glioblastoma; Humans; Paclitaxel; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2022
Novel Derivatives of Tetrahydrobenzo (g) Imidazo[α-1,2] Quinoline Induce Apoptosis Via ROS Production in the Glioblastoma Multiforme Cells, U-87MG. Asian Pacific journal of cancer prevention : APJCP, 2022, Nov-01, Volume: 23, Issue:11 Topics: Apoptosis; Glioblastoma; Humans; Paclitaxel; Quinolones; Reactive Oxygen Species	2022
The Formation of Morphologically Stable Lipid Nanocarriers for Glioma Therapy. International journal of molecular sciences, 2023, Feb-11, Volume: 24, Issue:4 Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Lipids; Liposomes; Paclitaxel; Rats; Rats, Wistar	2023
Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme. Scientific reports, 2023, 03-29, Volume: 13, Issue:1 Topics: Adult; Brain Neoplasms; Cell Line, Tumor; Delayed-Action Preparations; Glioblastoma; Humans; Hydrogels; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Paclitaxel; Temozolomide	2023
Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma. Proceedings of the National Academy of Sciences of the United States of America, 2023, 05-02, Volume: 120, Issue:18 Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Hydrogels; Immunotherapy; Neoplasm Recurrence, Local; Paclitaxel; Tumor Microenvironment; Tumor-Associated Macrophages	2023
μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment. ACS nano, 2023, 08-08, Volume: 17, Issue:15 Topics: Animals; Cell Line, Tumor; Docetaxel; Glioblastoma; Nanoparticles; Paclitaxel; Pharmaceutical Preparations; Polymers; Polyvinyl Alcohol	2023
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment. Nature communications, 2023, 08-15, Volume: 14, Issue:1 Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Glioblastoma; Gold; Humans; Metal Nanoparticles; Mice; Nanoparticles; Paclitaxel	2023
Blocking the functional domain of TIP1 by antibodies sensitizes cancer to radiation therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 166 Topics: Animals; Antibodies; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Glioblastoma; Humans; Lung Neoplasms; Mice; Paclitaxel	2023
Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study. Chemical & pharmaceutical bulletin, 2023, Volume: 71, Issue:10 Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression; Glioblastoma; Glycogen Synthase Kinase 3 beta; Humans; Molecular Docking Simulation; Paclitaxel; Temozolomide; Wnt Signaling Pathway	2023
Preparation of Cholera Toxin Subunit B Functionalized Nanoparticles for Targeted Therapy of Glioblastoma. Methods in molecular biology (Clifton, N.J.), 2020, Volume: 2059 Topics: Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cholera Toxin; Drug Carriers; Glioblastoma; Glycosphingolipids; Microscopy, Electron, Transmission; Nanoparticles; Neovascularization, Pathologic; Paclitaxel; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer	2020
A local combination therapy to inhibit GBM recurrence. Journal of controlled release : official journal of the Controlled Release Society, 2019, 09-10, Volume: 309 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Drug Carriers; Drug Delivery Systems; Glioblastoma; Humans; Hydrogels; Neoplasm Recurrence, Local; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Temozolomide	2019
Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. International journal of pharmaceutics, 2020, Mar-30, Volume: 578 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Combinations; Drug Liberation; Female; Flurbiprofen; Glioblastoma; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Tumor Burden	2020
Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma. ACS applied materials & interfaces, 2020, Apr-29, Volume: 12, Issue:17 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dextrans; Drug Carriers; Drug Liberation; Female; Glioblastoma; Humans; Hydrogen-Ion Concentration; Mice, Nude; Neoplasm Metastasis; Paclitaxel; Polyesters; Secondary Prevention; Tumor Microenvironment; Xenograft Model Antitumor Assays	2020
The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas. Journal of materials chemistry. B, 2019, 03-28, Volume: 7, Issue:12 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Line; Cell Survival; Chloroquine; Drug Delivery Systems; Folic Acid; Glioblastoma; Humans; Mice; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Serum Albumin, Bovine	2019
Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma. Journal of materials chemistry. B, 2020, 05-21, Volume: 8, Issue:19 Topics: Amphetamine; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cations; Cell Proliferation; Cell Survival; Drug Delivery Systems; Drug Liberation; Drug Screening Assays, Antitumor; Female; Glioblastoma; Lipids; Mice; Mice, Inbred C57BL; Molecular Structure; Nanoparticles; Paclitaxel; Particle Size; RNA, Small Interfering; Surface Properties; Tumor Cells, Cultured	2020
Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma. Nanomedicine (London, England), 2020, Volume: 15, Issue:14 Topics: Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Nanoparticles; Paclitaxel; RNA, Small Interfering	2020
Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Life sciences, 2020, Sep-01, Volume: 256 Topics: Animals; Antineoplastic Agents; Apolipoproteins; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Compounding; Drug Liberation; Endocytosis; Glioblastoma; Hemolysis; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Methotrexate; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-bcl-2; Rats	2020
Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma. ACS nano, 2020, 07-28, Volume: 14, Issue:7 Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Mice; Nanoparticles; Paclitaxel	2020
Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma. PloS one, 2020, Volume: 15, Issue:7 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Central Nervous System; Drug Carriers; Glioblastoma; Humans; Hydrogels; Mice; Mice, Inbred NOD; Mice, SCID; Paclitaxel; Peptides; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays	2020
Fabrication of poly(acrylic acid) grafted-chitosan/polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells. International journal of pharmaceutics, 2020, Sep-25, Volume: 587 Topics: Acrylic Resins; Cell Line, Tumor; Chitosan; Glioblastoma; Humans; Magnetic Phenomena; Metal-Organic Frameworks; Nanofibers; Paclitaxel; Polyurethanes; Temozolomide	2020
Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. International journal of nanomedicine, 2020, Volume: 15 Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Endothelial Cells; Glioblastoma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Receptors, Transferrin; Xenograft Model Antitumor Assays	2020
Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip. Biotechnology letters, 2021, Volume: 43, Issue:2 Topics: Astrocytes; Blood-Brain Barrier; Brain; Capecitabine; Coculture Techniques; Endothelial Cells; Glioblastoma; Hep G2 Cells; Humans; Inactivation, Metabolic; Lab-On-A-Chip Devices; Liver; Nanoparticles; Paclitaxel; Temozolomide	2021
Tracking the Footprints of Paclitaxel Delivery and Mechanistic Action via SERS Trajectory in Glioblastoma Cells. ACS biomaterials science & engineering, 2020, 09-14, Volume: 6, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Paclitaxel	2020
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 138 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Estrogen Antagonists; Female; Flavanones; Glioblastoma; Lipids; Male; Nanoparticles; Paclitaxel; Particle Size; Peptides, Cyclic; Rats; Rats, Wistar	2021
Effect of Paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma. International journal of pharmaceutics, 2021, Jul-15, Volume: 604 Topics: Animals; Cell Line, Tumor; Drug Carriers; Etoposide; Glioblastoma; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats; Survival Rate	2021
Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance. Drug delivery and translational research, 2022, Volume: 12, Issue:5 Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dendrimers; Drug Resistance; Drug Resistance, Neoplasm; Glioblastoma; Humans; Paclitaxel; Stem Cells; Temozolomide	2022
Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma. Journal of controlled release : official journal of the Controlled Release Society, 2017, 05-28, Volume: 254 Topics: Adipocytes; Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Dacarbazine; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Lactic Acid; Magnetite Nanoparticles; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Oleic Acid; Paclitaxel; Particle Size; Permeability; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stem Cells; Surface Properties; Temozolomide; Tissue Distribution	2017
Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study. Cytotherapy, 2017, Volume: 19, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Coculture Techniques; Drug Carriers; Drug Delivery Systems; Fibronectins; Glioblastoma; Humans; Leukocytes, Mononuclear; Middle Aged; Paclitaxel	2017
Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines. Veterinary journal (London, England : 1997), 2017, Volume: 223 Topics: Adipose Tissue; Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Cell Line, Tumor; Dogs; Drug Delivery Systems; Glioblastoma; Glioma; Humans; Mesenchymal Stem Cells; Paclitaxel	2017
Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. International journal of nanomedicine, 2017, Volume: 12 Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Drug Delivery Systems; Glioblastoma; Humans; Liposomes; Magnetic Resonance Imaging; Male; Mice, Nude; Microbubbles; Paclitaxel; Ultrasonography; Xenograft Model Antitumor Assays	2017
Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy. Drug delivery, 2017, Volume: 24, Issue:1 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel	2017
Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma. Bioconjugate chemistry, 2017, 11-15, Volume: 28, Issue:11 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Peptides; Proteins; Rats	2017
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. eLife, 2017, 10-04, Volume: 6 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Drug Carriers; Drug Synergism; Drug Therapy; Glioblastoma; Glycerol; Humans; Mice; P-Selectin; Paclitaxel; Polymers; Protein Binding; Thrombospondin 1; Treatment Outcome	2017
Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles. Nanoscale, 2017, Oct-19, Volume: 9, Issue:40 Topics: Blood-Brain Barrier; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Glioblastoma; Humans; Lipids; Nanoparticles; Paclitaxel; Particle Size; Permeability; Temperature	2017
BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment. Pharmacological research, 2018, Volume: 132 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Delivery Systems; Endothelin Receptor Antagonists; Glioblastoma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Peptides, Cyclic	2018
Nanomedicines in the treatment of brain tumors. Nanomedicine (London, England), 2018, Volume: 13, Issue:6 Topics: Brain Neoplasms; Doxorubicin; Drug Delivery Systems; Glioblastoma; Humans; Nanomedicine; Nanoparticles; Paclitaxel; Theranostic Nanomedicine	2018
Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; Apolipoproteins E; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Drug Liberation; Extracorporeal Shockwave Therapy; Female; Gene Expression; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Polysorbates; Survival Analysis; Tight Junctions	2018
Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival. International journal of pharmaceutics, 2018, Sep-05, Volume: 548, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Delayed-Action Preparations; Drug Liberation; Female; Glioblastoma; Humans; Hydrogels; Intraoperative Period; Lactic Acid; Methacrylates; Mice; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer	2018
Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel. International journal of radiation biology, 2018, Volume: 94, Issue:11 Topics: Animals; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Folic Acid; Glioblastoma; Intracellular Space; Magnetite Nanoparticles; Paclitaxel; Proton Therapy; Radiation-Sensitizing Agents; Rats	2018
Magnetic targeting of paclitaxel-loaded poly(lactic- International journal of nanomedicine, 2018, Volume: 13 Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Endocytosis; Female; Glioblastoma; Humans; Lactic Acid; Magnetics; Mice, Nude; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays	2018
Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. International journal of pharmaceutics, 2018, Dec-20, Volume: 553, Issue:1-2 Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cattle; Cell Line, Tumor; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Endothelial Cells; Glioblastoma; Glioma; Humans; Nanoparticles; Paclitaxel; Peptides; Polymers; Rats; Rats, Sprague-Dawley; Receptors, LDL; Tissue Distribution	2018
Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment. International journal of pharmaceutics, 2019, Mar-25, Volume: 559 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Combinations; Drug Liberation; Gemcitabine; Glioblastoma; Hydrogels; Injections; Lipids; Mice; Nanocapsules; Nanomedicine; Paclitaxel; Rats	2019
High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme. ACS nano, 2019, 02-26, Volume: 13, Issue:2 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Delivery Systems; Female; Flow Cytometry; Glioblastoma; Humans; Immunohistochemistry; Immunotherapy; Lipoproteins, HDL; Lomustine; Mice; Models, Biological; Paclitaxel; Rats; T-Lymphocytes	2019
Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells. Oxidative medicine and cellular longevity, 2019, Volume: 2019 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Glioblastoma; Humans; Oxidants; Paclitaxel; Reactive Oxygen Species; Resveratrol; TRPM Cation Channels	2019
Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. ACS nano, 2019, 07-23, Volume: 13, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Liberation; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Hydrogels; Hydrophobic and Hydrophilic Interactions; Macromolecular Substances; Nanostructures; Paclitaxel; Particle Size; Prodrugs; Structure-Activity Relationship; Surface Properties	2019
Peptide-guided nanoparticles for glioblastoma targeting. Journal of controlled release : official journal of the Controlled Release Society, 2019, 08-28, Volume: 308 Topics: Albumins; Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Endothelial Cells; Female; Ferric Compounds; Glioblastoma; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Paclitaxel; Peptides; Silver; Xenograft Model Antitumor Assays	2019
Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. Journal of controlled release : official journal of the Controlled Release Society, 2019, 09-10, Volume: 309 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Combinations; Drug Delivery Systems; Female; Glioblastoma; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mice, Nude; Neoplasm Recurrence, Local; Paclitaxel; Temozolomide	2019
Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2019, Volume: 27, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Exosomes; Glioblastoma; Humans; Paclitaxel; Particle Size	2019
Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier. Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 21 Topics: Animals; Aptamers, Nucleotide; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Nanoconjugates; Paclitaxel; Rats	2019
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. Journal of the National Cancer Institute, 2013, Sep-04, Volume: 105, Issue:17 Topics: 2-Aminopurine; Animals; Antimitotic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Cell Survival; Drug Resistance, Neoplasm; France; Frozen Sections; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Netherlands; ortho-Aminobenzoates; Paclitaxel; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA Interference; United States; Up-Regulation; Vincristine; Xenograft Model Antitumor Assays	2013
Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma. Biochemical and biophysical research communications, 2013, Nov-01, Volume: 440, Issue:4 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Humans; Oxidation-Reduction; Oxidoreductases Acting on CH-CH Group Donors; Paclitaxel; Reactive Oxygen Species; Temozolomide	2013
Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro. Radiation oncology (London, England), 2013, Nov-06, Volume: 8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carbon; Cell Cycle; Cell Line, Tumor; Cell Separation; Chemoradiotherapy; Cisplatin; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Glioblastoma; Humans; Ions; Lung Neoplasms; Paclitaxel; Pancreatic Neoplasms; Photons; Propidium; Radiotherapy; Relative Biological Effectiveness; Time Factors	2013
Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel. Pharmaceutical research, 2014, Volume: 31, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Delayed-Action Preparations; Emulsions; Glioblastoma; Humans; Materials Testing; Nanoparticles; Paclitaxel; Thermodynamics	2014
Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics. The Journal of biological chemistry, 2014, Oct-17, Volume: 289, Issue:42 Topics: Antineoplastic Agents; Apoptosis; Cytoskeleton; Endocytosis; Glioblastoma; HeLa Cells; Hep G2 Cells; Humans; MCF-7 Cells; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms; Nocodazole; Paclitaxel; Peptides; Prions; Protein Structure, Tertiary; tau Proteins; Tubulin	2014
Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. International journal of nanomedicine, 2014, Volume: 9 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Fibrin; Glioblastoma; Humans; Lactates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Polyethylene Glycols; Random Allocation; Survival Analysis; Xenograft Model Antitumor Assays	2014
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Glioblastoma; Humans; Lipids; Nanoparticles; Paclitaxel; Particle Size; Surface Properties	2014
Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma. Cytotherapy, 2015, Volume: 17, Issue:3 Topics: Antineoplastic Agents; Cancer Vaccines; Cell Differentiation; Cell Line; Cell Proliferation; Cell- and Tissue-Based Therapy; Culture Media, Conditioned; Dendritic Cells; Drug Delivery Systems; Glioblastoma; Humans; Lipopolysaccharide Receptors; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Paclitaxel	2015
Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting. Colloids and surfaces. B, Biointerfaces, 2015, Feb-01, Volume: 126 Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Lipids; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polymers; Structure-Activity Relationship; Xenograft Model Antitumor Assays	2015
The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment. International journal of oncology, 2015, Volume: 46, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Damage; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Glioblastoma; Humans; Paclitaxel; Temozolomide	2015
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy. Oncotarget, 2015, May-20, Volume: 6, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Dacarbazine; Doxorubicin; Genotype; Glioblastoma; Humans; Kaplan-Meier Estimate; Paclitaxel; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proteins; Temozolomide; Valproic Acid	2015
Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy. ACS nano, 2015, May-26, Volume: 9, Issue:5 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chlorophyllides; Combined Modality Therapy; Female; Glioblastoma; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Models, Molecular; Molecular Targeted Therapy; Oligopeptides; Paclitaxel; Porphyrins; Protein Aggregates; Protein Conformation; Serum Albumin; Theranostic Nanomedicine	2015
Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Molecular pharmaceutics, 2015, Aug-03, Volume: 12, Issue:8 Topics: Animals; Antigens, CD; Apoptosis; Blood-Brain Barrier; Brain; Cell Proliferation; Cells, Cultured; Drug Delivery Systems; Glioblastoma; Iron; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Peptide Fragments; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Tissue Distribution; Transferrin	2015
Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy. Bioconjugate chemistry, 2015, Aug-19, Volume: 26, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Delivery Systems; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Peptide Fragments; Polyethylene Glycols	2015
Characterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic Analyses. PloS one, 2015, Volume: 10, Issue:8 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Astrocytes; Brain Neoplasms; Breast; Breast Neoplasms; Cell Line; Cell Line, Tumor; Computer Simulation; Elasticity; Female; Glioblastoma; Humans; MCF-7 Cells; Models, Biological; Paclitaxel; Ultrasonic Therapy; Ultrasonic Waves	2015
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma. International journal of pharmaceutics, 2015, Nov-30, Volume: 495, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chitosan; Drug Screening Assays, Antitumor; Drug Stability; Female; Glioblastoma; Lipids; Magnetic Resonance Imaging; Mice; Nanocapsules; Oligodeoxyribonucleotides; Paclitaxel	2015
Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts. Stem cell research & therapy, 2015, Oct-06, Volume: 6 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Paclitaxel; Rats; Rats, Wistar	2015
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Scientific reports, 2015, Nov-16, Volume: 5 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Glioblastoma; Interleukin-13 Receptor alpha2 Subunit; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Paclitaxel; Rats; Tissue Distribution; Xenograft Model Antitumor Assays	2015
Polymer Nanocomposites Based Thermo-Sensitive Gel for Paclitaxel and Temozolomide Co-Delivery to Glioblastoma Cells. Journal of nanoscience and nanotechnology, 2015, Volume: 15, Issue:12 Topics: Animals; Cell Line, Tumor; Dacarbazine; Drug Carriers; Glioblastoma; Humans; Nanocomposites; Paclitaxel; Polyesters; Polyethylene Glycols; Rats; Temozolomide	2015
The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells. Oncotarget, 2016, Apr-12, Volume: 7, Issue:15 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dacarbazine; Drug Carriers; Drug Delivery Systems; Drug Synergism; Female; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Polyesters; Polyethylene Glycols; Rats; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2016
Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Biomaterials, 2016, Volume: 101 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Neuropilin-1; Paclitaxel; Peptides; Tenascin	2016
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery t Oncotarget, 2016, 09-27, Volume: 7, Issue:39 Topics: Animals; Apoptosis; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemotaxis; Cyclic GMP-Dependent Protein Kinase Type I; Dacarbazine; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Male; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Neurons; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phenotype; Stem Cells; Temozolomide	2016
Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates. Journal of colloid and interface science, 2017, Mar-15, Volume: 490 Topics: Animals; Antineoplastic Agents, Phytogenic; Aptamers, Nucleotide; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoconjugates; Oligodeoxyribonucleotides; Paclitaxel; Proteins	2017
Mesoporous carbon nanoshells for high hydrophobic drug loading, multimodal optical imaging, controlled drug release, and synergistic therapy. Nanoscale, 2017, Jan-26, Volume: 9, Issue:4 Topics: Animals; Carbon; Drug Carriers; Drug Liberation; Glioblastoma; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Nude; Nanoshells; Paclitaxel; Rats; Xenograft Model Antitumor Assays	2017
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts. Stem cell research & therapy, 2017, 03-09, Volume: 8, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Glioblastoma; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Paclitaxel; Rats; Xenograft Model Antitumor Assays	2017
Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells. Apoptosis : an international journal on programmed cell death, 2008, Volume: 13, Issue:10 Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Enzyme Activation; G1 Phase; Gene Library; Glioblastoma; Humans; JNK Mitogen-Activated Protein Kinases; Models, Biological; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; ran GTP-Binding Protein; Reactive Oxygen Species; Saccharomyces cerevisiae	2008
Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Brain research, 2008, Nov-06, Volume: 1239 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Line, Tumor; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Glioblastoma; Humans; Mitochondria; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Signal Transduction; Vascular Endothelial Growth Factor A	2008
N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells. Brain research, 2009, May-01, Volume: 1268 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Astrocytes; Cadherins; Calpain; Cathepsins; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; Fenretinide; Gene Expression; Glioblastoma; Inhibitor of Differentiation Protein 2; Paclitaxel; Proliferating Cell Nuclear Antigen; Rats; Telomerase; Tumor Suppressor Proteins	2009
Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials, 2009, Volume: 30, Issue:18 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Tumor; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Evaluation, Preclinical; Drug Implants; Glioblastoma; Lactic Acid; Mice; Mice, Inbred BALB C; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rats; Rats, Wistar; Tissue Distribution	2009
Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth. Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:10 Topics: Animals; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; In Situ Nick-End Labeling; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Small Interfering; Subcutaneous Tissue; Xenograft Model Antitumor Assays	2009
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. Journal of neuro-oncology, 2010, Volume: 97, Issue:2 Topics: Animals; Brain Neoplasms; Cell Separation; Combined Modality Therapy; Convection; Female; Flow Cytometry; Glioblastoma; Microscopy, Confocal; Nanocapsules; Nanotechnology; Paclitaxel; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344	2010
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Molecular cancer therapeutics, 2009, Volume: 8, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Synergism; Fluorodeoxyglucose F18; Glioblastoma; Humans; Luminescent Measurements; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53; X-Ray Microtomography; Xenograft Model Antitumor Assays	2009
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Journal of controlled release : official journal of the Controlled Release Society, 2010, Apr-02, Volume: 143, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Glioblastoma; Humans; Inhibitory Concentration 50; Injections, Intravenous; Integrin alphaVbeta3; Lactates; Mice; Mice, Nude; Micelles; Paclitaxel; Particle Size; Peptides, Cyclic; Polyethylene Glycols; Technology, Pharmaceutical; Tumor Burden; Xenograft Model Antitumor Assays	2010
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC cancer, 2010, Jan-31, Volume: 10 Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitory Concentration 50; MicroRNAs; Models, Biological; Paclitaxel; Phosphorylation; PTEN Phosphohydrolase; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles	2010
Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells. Neuroscience letters, 2010, Apr-26, Volume: 474, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Diphosphonates; Drug Synergism; Flow Cytometry; Geranyltranstransferase; Glioblastoma; Humans; JNK Mitogen-Activated Protein Kinases; Mevalonic Acid; Paclitaxel; Pamidronate; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction; Time Factors; Tumor Suppressor Protein p53	2010
The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials, 2010, Volume: 31, Issue:19 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Implants; Glioblastoma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Nanostructures; Paclitaxel; Treatment Outcome	2010
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. International journal of pharmaceutics, 2010, Dec-15, Volume: 402, Issue:1-2 Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Stability; Drug Storage; Emulsions; Glioblastoma; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Time Factors	2010
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:5 Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Glutathione; Humans; Inactivation, Metabolic; Paclitaxel; Rhodamine 123; RNA, Messenger; Vascular Endothelial Growth Factor A	2011
Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells. Neurochemical research, 2011, Volume: 36, Issue:12 Topics: Albumin-Bound Paclitaxel; Albumins; Apoptosis; Apoptosis Inducing Factor; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Caspase 3; Caspase 8; Caspase 9; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cytochromes c; Down-Regulation; Drug Therapy, Combination; Glioblastoma; Humans; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Valproic Acid	2011
PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. International journal of pharmaceutics, 2011, Nov-28, Volume: 420, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Dioxanes; Drug Carriers; Female; Glioblastoma; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution	2011
Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. Cancer investigation, 2012, Volume: 30, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Central Nervous System Neoplasms; Ceramides; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Glucosyltransferases; Humans; Paclitaxel; Temozolomide	2012
Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis. Cell biology international, 2012, Volume: 36, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Down-Regulation; Ether-A-Go-Go Potassium Channels; Glioblastoma; Humans; MicroRNAs; Oligonucleotides, Antisense; Paclitaxel	2012
In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiation oncology (London, England), 2012, Jan-27, Volume: 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbon; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; Deoxycytidine; Dose-Response Relationship, Radiation; Gemcitabine; Glioblastoma; Humans; In Vitro Techniques; Paclitaxel; Photons; Tumor Stem Cell Assay	2012
Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling. Investigational new drugs, 2012, Volume: 30, Issue:6 Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cisplatin; Doxorubicin; Glioblastoma; Humans; Leupeptins; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; NF-kappa B; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Proteasome Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2012
Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-28, Volume: 160, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Male; Mice; Mice, Inbred BALB C; Paclitaxel; Peptides; Peptides, Cyclic; Plasmids; Polyethylene Glycols; Polyethyleneimine; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Burden	2012
Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells. PloS one, 2012, Volume: 7, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspases; Cell Line, Tumor; Glioblastoma; Humans; Integrin alphaVbeta3; Paclitaxel; Peptides, Cyclic	2012
The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts. BMC cancer, 2012, Jun-13, Volume: 12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays	2012
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials, 2012, Volume: 33, Issue:32 Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Nanoparticles; Paclitaxel; Peptides; Polyethylene Glycols	2012
Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochemistry international, 2012, Volume: 61, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line; Curcumin; Drug Synergism; Glioblastoma; Humans; Microscopy, Fluorescence; Neoplastic Stem Cells; Paclitaxel	2012
Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy. Cancer letters, 2013, Jul-01, Volume: 334, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Glioblastoma; Humans; Male; Nanostructures; Paclitaxel; Phosphorylcholine; Rats; Rats, Wistar	2013
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Biomaterials, 2013, Volume: 34, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coumarins; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Ethylene Oxide; Glioblastoma; Kaplan-Meier Estimate; Lactones; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; Paclitaxel; Protamines; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution	2013
Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy. Oncotarget, 2013, Volume: 4, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Drug Carriers; Drug Delivery Systems; Glioblastoma; Green Fluorescent Proteins; Humans; Luciferases; Mice; Mice, Nude; Micelles; Microscopy, Fluorescence; Nanostructures; Paclitaxel; Polymers; Treatment Outcome; Xenograft Model Antitumor Assays	2013
The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells. Biomaterials, 2013, Volume: 34, Issue:13 Topics: Animals; Astrocytes; Brain; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Female; Glioblastoma; Lipids; Mice; Mice, Inbred C57BL; Nanocapsules; Neurofilament Proteins; Paclitaxel; Peptide Fragments; Protein Binding	2013
Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells. Chemotherapy, 2002, Volume: 48, Issue:4 Topics: Antineoplastic Agents, Phytogenic; bcl-X Protein; Blotting, Western; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Humans; Oligonucleotides, Antisense; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	2002
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. The Journal of clinical investigation, 2002, Volume: 110, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillaries; Cells, Cultured; Cyclosporins; Glioblastoma; Glioma; Humans; Paclitaxel; Swine; Tumor Cells, Cultured	2002
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). International journal of cancer, 2003, Mar-10, Volume: 104, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Capillaries; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelium, Vascular; Fibrosarcoma; Glioblastoma; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Rats; Taxoids; Tumor Cells, Cultured; Umbilical Veins; Xenograft Model Antitumor Assays	2003
Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology, 2003, Mar-11, Volume: 60, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	2003
IDN 5390: an oral taxane candidate for protracted treatment schedules. British journal of cancer, 2003, Mar-24, Volume: 88, Issue:6 Topics: Administration, Oral; Animals; Brain Neoplasms; Bridged-Ring Compounds; Carcinoma; Colonic Neoplasms; Drug Administration Schedule; Female; Glioblastoma; Humans; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasms, Experimental; Ovarian Neoplasms; Paclitaxel; Taxoids; Transplantation, Heterologous	2003
Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer research, 2005, Feb-01, Volume: 65, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzimidazoles; Cell Growth Processes; Female; Glioblastoma; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Quinolines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Xenograft Model Antitumor Assays	2005
Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases. Journal of neuro-oncology, 2005, Volume: 72, Issue:3 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Carboplatin; Crystallization; Diffusion; Drug Carriers; Drug Compounding; Drug Delivery Systems; Glioblastoma; Male; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Survival	2005
Intracavitary chemotherapy (paclitaxel/carboplatin liquid crystalline cubic phases) for recurrent glioblastoma -- clinical observations. Journal of neuro-oncology, 2005, Volume: 74, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Brain Neoplasms; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Carriers; Drug Delivery Systems; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects; Survival Analysis	2005
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma. International journal of oncology, 2006, Volume: 28, Issue:6 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioblastoma; Glioma; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-alpha; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Polyethylene Glycols; Transplantation, Heterologous	2006
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:2 Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Flow Cytometry; Fluoresceins; Glioblastoma; Humans; Insecticides; Kinesins; Molecular Structure; Paclitaxel; Pyrimidines; Quinazolines; Rotenone; Spindle Apparatus; Tetrahydroisoquinolines; Thiones; Time Factors; Tubulin; Tubulin Modulators; Vinblastine	2007
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells. Molecular pharmacology, 2007, Volume: 72, Issue:1 Topics: Adenosine; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-Associated Death Protein; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptor, Adenosine A3	2007
Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells. Neurochemical research, 2007, Volume: 32, Issue:8 Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Child; Glioblastoma; Humans; Multiprotein Complexes; Nocodazole; Paclitaxel; Tubulin; Tubulin Modulators; Vinblastine	2007
Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochemical research, 2007, Volume: 32, Issue:12 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Calcium; Caspase 8; Cell Differentiation; Cell Line, Tumor; DNA Fragmentation; Electrophoretic Mobility Shift Assay; Enzyme Activation; Glioblastoma; Interferon-gamma; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-raf; Rats; Recombinant Proteins; Retinoids; Telomerase	2007
Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis : an international journal on programmed cell death, 2007, Volume: 12, Issue:11 Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Female; Glioblastoma; Graft Survival; Humans; Mice; Mice, Nude; Paclitaxel; Transplantation, Heterologous; Tretinoin	2007
Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. Journal of controlled release : official journal of the Controlled Release Society, 2007, Dec-20, Volume: 124, Issue:3 Topics: Amino Acids; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Emulsions; Feasibility Studies; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glioblastoma; Humans; Inhibitory Concentration 50; Lipoproteins, LDL; Microscopy, Fluorescence; Nanoparticles; Oleic Acid; Paclitaxel; Particle Size; Peptides; Pharmaceutical Vehicles; Protein Structure, Tertiary; Receptors, LDL	2007
Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. Journal of neuro-oncology, 2008, Volume: 87, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Astrocytes; Blotting, Western; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Down-Regulation; Glioblastoma; Humans; Isotretinoin; Paclitaxel; Reactive Oxygen Species; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Telomerase; Tretinoin	2008
Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer, 2008, Feb-01, Volume: 112, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Differentiation; Cell Line, Tumor; Central Nervous System Neoplasms; Cysteine Endopeptidases; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Paclitaxel; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Telomerase; Tretinoin; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays	2008
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy, 2008, Volume: 4, Issue:4 Topics: Animals; Antibodies; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Ceramides; Dacarbazine; Female; Glioblastoma; Humans; Mice; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Oxides; Paclitaxel; Phagosomes; Survival Rate; Temozolomide; Transplantation, Heterologous; Tubulin Modulators	2008
Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochemical research, 2009, Volume: 34, Issue:1 Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Calcium; Calpain; Caspase 3; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Down-Regulation; Fluorescent Antibody Technique; Glioblastoma; Humans; In Situ Nick-End Labeling; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering	2009
In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anti-cancer drugs, 1995, Volume: 6, Issue:2 Topics: Cell Movement; Glioblastoma; Humans; Paclitaxel; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995
A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anti-cancer drugs, 1993, Volume: 4, Issue:4 Topics: Brain Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Kinetics; Neuroblastoma; Neuroectodermal Tumors, Primitive; Paclitaxel; Tumor Cells, Cultured	1993
Thromboembolic events with paclitaxel. Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Paclitaxel; Radiation-Sensitizing Agents; Thromboembolism	1996
The development of a novel intraperitoneal tumor-seeding prophylactic. American journal of surgery, 1997, Volume: 173, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Glioblastoma; Injections, Intraperitoneal; Microspheres; Neoplasm Seeding; Neoplasm Transplantation; Paclitaxel; Peritoneal Neoplasms; Rats; Rats, Wistar	1997
Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. British journal of cancer, 1997, Volume: 75, Issue:12 Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Division; Cell Movement; Female; Flow Cytometry; Glioblastoma; Glioma; Glycerol; Humans; Microscopy, Confocal; Paclitaxel; Rats; Rats, Wistar; Solvents; Spheroids, Cellular; Tumor Cells, Cultured	1997
Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. International journal of radiation oncology, biology, physics, 1998, Feb-01, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiation-Sensitizing Agents; Radiosurgery	1998
Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol. Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2 Topics: Actuarial Analysis; Adult; Aged; Brain; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pilot Projects; Radiation-Sensitizing Agents; Radiosurgery; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome	1997
Interaction of paclitaxel (Taxol) and irradiation. In-vitro differences between tumor and fibroblastic cells. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:4 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fibroblasts; Flow Cytometry; Glioblastoma; Humans; Lung Neoplasms; Paclitaxel; Particle Accelerators; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Rodentia; Time Factors; Tumor Cells, Cultured	1999
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer research, 1999, Aug-01, Volume: 59, Issue:15 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blood Vessels; Brain Neoplasms; Docetaxel; Female; Glioblastoma; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Pressure; Sarcoma, Experimental; Specific Pathogen-Free Organisms; Taxoids; Tumor Cells, Cultured	1999
Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. Biomaterials, 2000, Volume: 21, Issue:19 Topics: Animals; Carbon Dioxide; Cecum; Drug Delivery Systems; Glioblastoma; Insufflation; Intraoperative Complications; Lactic Acid; Male; Microspheres; Paclitaxel; Peritoneal Cavity; Polyesters; Polymers; Rats; Rats, Wistar	2000
[Roles of p53 in chemotherapy of glioblastoma]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2000, Volume: 75, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cisplatin; Etoposide; Flow Cytometry; Glioblastoma; Nimustine; Paclitaxel; Polymerase Chain Reaction; Temperature; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2000
Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. International journal of pharmaceutics, 2002, May-15, Volume: 238, Issue:1-2 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carmustine; Dose-Response Relationship, Drug; Drug Implants; Excipients; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Polymers	2002